Subcutaneous (subQ or SQ) injections are shots given in the fatty tissue layer (subcutaneous fat) under your skin. Your skin has many layers, and the subcutaneous layer is beneath the epidermis ...

A long-acting medicine developed by Novo Nordisk has been recommended as a treatment option for young people with growth ...

Therefore, a single 1-ml subcutaneous injection could readily translate to a dose of 5 mg per kilogram or greater in infants and in children younger than 5 years of age, possibly providing ...

Traditionally, hemophilia with inhibitors has been managed with intravenous (IV) infusions; concizumab shifts the paradigm with a subcutaneous injection ... for adults and children 12 years ...

The Food and Drug Administration (FDA) approved Tecentriq Hybreza (atezolizumab and hyaluronidase-tqjs), a subcutaneous injection, for all previously approved indications of the intravenous ...

The FDA approved ocrelizumab and hyaluronidase-ocsq (Ocrevus Zunovo; Genentech), a twice-yearly subcutaneous injection, for relapsing multiple sclerosis (RMS) and primary progressive multiple ...